Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases

Male 0301 basic medicine Time Factors Adolescent Biopsy Amyloidosis Kidney Arthritis, Juvenile Cryopyrin-Associated Periodic Syndromes 3. Good health Interleukin 1 Receptor Antagonist Protein Proteinuria 03 medical and health sciences Treatment Outcome 0302 clinical medicine Child, Preschool Disease Progression Humans Immunologic Factors Female Kidney Diseases Child Retrospective Studies
DOI: 10.1007/s00467-015-3249-5 Publication Date: 2015-11-12T11:46:57Z
ABSTRACT
Amyloidosis may complicate autoinflammatory diseases (AID). We aimed to evaluate the renal biopsy findings, and clinical and laboratory parameters in patients with AID-associated amyloidosis who have responded to anti-interleukin 1(IL1) treatment.Two children with systemic juvenile idiopathic arthritis and one with cryopyrin-associated periodic syndrome diagnosed as having reactive amyloidosis were treated with anti-IL1 drugs. The renal histopathological findings at the time of diagnosis of amyloidosis and after the onset of anti-IL1 were evaluated according to the amyloid scoring/grading system.The median age of disease onset and diagnosis of amyloidosis were 3 and 12 years, respectively. Anakinra was started in all; however, anakinra caused a local cutaneous reaction in one, thus canakinumab was commenced. Proteinuria improved in all. Control renal biopsies were performed a median of 3 years after the first biopsies. The renal amyloid prognostic score did not improve in patient 1, and progressed in patients 2 and 3. The renal amyloid grade progressed in patient 2.This is the first series demonstrating progression of renal tissue damage after the improvement of proteinuria with anti-IL 1 in AID-associated amyloidosis. Anti-IL1 drugs are important to prevent further amyloid accumulation; however, new treatment strategies are needed to target the amyloid deposits.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (50)
CITATIONS (26)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....